Humacyte, Inc. Class Action Lawsuit Alert: Johnson Fistel – GlobeNewswire

ohnson Fistel, LLP just announced some important news for investors in Humacyte, Inc. (NASDAQ: HUMA). If you’re someone who invested in this company between May 10, 2024, and October 17, 2024, you might want to pay attention to this. There’s a class action lawsuit happening, and it aims to help investors recover any losses they may have experienced during that time.

You have until January 17, 2025, to apply to the Court if you want to be considered as the lead plaintiff in this lawsuit. This could give you the opportunity to take the lead in representing all other investors in this class-action case. If you’re interested in learning more about this lawsuit and figuring out if you might be eligible for a recovery of your losses, you can submit your details on Johnson Fistel’s website here: [link to the investigation page].

According to the lawsuit, there were some issues at Humacyte’s facility in Durham, North Carolina that weren’t in compliance with good manufacturing practices, including quality assurance and microbial testing. This resulted in a delay in the Food and Drug Administration’s (FDA) review of the Biologics License Application (BLA) as Humacyte worked on fixing these problems. As a result, there was a risk to the FDA’s approval of Acellular Tissue Engineered Vessel (ATEV) for vascular trauma. When this information became public, investors suffered financial losses.

If you lost money during the time frame of this class action lawsuit, up until January 17, 2025, you can take steps to become the lead plaintiff in this case. This could involve selecting the law firm that will handle the lawsuit on behalf of all investors in the class. Remember, being a lead plaintiff doesn’t impact your ability to share in any potential recovery from the lawsuit.

Johnson Fistel, LLP is a well-known law firm that specializes in shareholder rights. They have offices in California, New York, Georgia, and Colorado. If you want to stay informed about stock market news and how Johnson Fistel, LLP can assist you in recovering your losses, you can find more information on their website: [link to the firm’s website].

Please note that this article contains attorney advertising. Past results in legal cases don’t guarantee future outcomes, but it’s good to know that Johnson Fistel, LLP is the law firm responsible for this information.

For any additional information, you can contact Johnson Fistel, LLP at 501 W. Broadway, Suite 800, San Diego, CA 92101. You can reach out to James Baker for Investor Relations or Frank J. Johnson, Esq. at (619) 814-4471 or via email at [email protected] or [email protected].